Eric Lefkofsky, founder and CEO of Tempest AI, explains the impact of acquiring Ambry, a genetic testing company, which ...

Experts say Investors may be valuing AI companies too generously if health systems can’t justify the costs of these tools.

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares ...

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. On January 22, Lefkofsky sold ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), recently sold a significant portion of his holdings, ...

At the Chicago-based company's first J.P. Morgan conference since going public in June, Tempus founder and CEO Eric Lefkofsky painted a bright and bold picture of the future of artificial ...

Shares of Tempus AI (TEM) are down 92c, or 2%, to $49.53 in Thursday morning trading after it was disclosed in a regulatory filing last night ...

Despite softness in the contract research organization revenues, core businesses gained momentum throughout the year, Tempus founder and CEO Eric Lefkofsky said in the statement. Tempus underlined ...

Tempus AI CEO Eric Lefkofsky said that genomics revenue is expected to rise by 30% in the fourth quarter, while data and services revenue is expected to be up 45%. Tempus is an AI company focused ...